Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through the end of November.
Acceleron Pharma Inc (XLRN)
Market is closed
News
- First
- << Previous
- 21 - 30
Is Acceleron Pharma Inc (XLRN) Going to Burn These Hedge Funds?
Most investors tend to think that hedge funds and other asset managers are worthless, as they cannot beat even simple index fund portfolios.
Here's What Hedge Funds Think About Acceleron Pharma Inc (XLRN)
The fourth quarter was a rough one for most investors, as fears of a rising interest rate environment in the U.S, a trade war with China, and a more or less stagnant Europe, weighed heavily on the minds...
Is Acceleron Pharma Inc (XLRN) A Good Stock To Buy?
Is Acceleron Pharma Inc (NASDAQ:XLRN) a good bet right now? We like to analyze hedge fund sentiment before doing days of in-depth research.
Former CEO of Finish Line Inc. (FINL) Sells Shares as Underperformance Persists; Other Notable Insider Transactions
It is already common knowledge that corporate insiders are savvy long-term-oriented investors, with their purchases beating broader market benchmarks on aggregate.
Hedge Funds Are Buying Acceleron Pharma Inc (XLRN)
At Insider Monkey we track the activity of some of the best-performing hedge funds like Appaloosa Management, Baupost, and Third Point because we determined that some of the stocks that they are collectively...
QVT Financial Reduces Exposure to Healthcare Going Into 2016; Here Are Its Top Stock Picks
QVT Financial is a New York-based long/short equity hedge fund founded by Daniel Gold in 2003. Prior to founding QVT Financial, Mr. Gold worked as a proprietary trader at Deutsche Bank.
Hedge Funds Are Dumping Acceleron Pharma Inc (XLRN)
It's a little-known fact that stock performance is not evenly distributed (i.e. you don't have a 50/50 chance of picking a market-beating stock).
Foresite Capital Betting It All On These Four Healthcare Stocks
Jim Tananbaum’s Foresite Capital has filed its latest 13F with the Securities and Exchange Commission for the reporting period of March 31, disclosing the long positions held in its equity portfolio...
Tekmira Pharmaceuticals Corp (TKMR): QVT Financial's New Holding and Two Other Healthcare Picks
Daniel Gold’s QVT Financial has disclosed a new stake in Tekmira Pharmaceuticals Corp (NASDAQ:TKMR). According to the 13D Form filed with the U.S.
- First
- << Previous
- 21 - 30
Billionaire Hedge Funds
